Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 May 2019 | Story Lacea Loader | Photo Robin Thuynsma
Mr Nikile Ntsababa
Mr Nikile Ntsababa.

Mr Nikile Ntsababa took up the position of Registrar at the University of the Free State (UFS) on 1 May 2019. His appointment was approved by the UFS Council during its quarterly meeting on 15 March 2019.
 
“Mr Ntsababa is an experienced and knowledgeable university registrar with 10 years of senior management experience in institutional compliance, regulatory compliance, academic administration, and university records management. His history of senior roles in the higher-education sector has the advantage of a very good understanding regarding the dynamics, context, and challenges that the position of registrar brings,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
 
He holds a Postgraduate Diploma in Records and Archives Management from the University of Fort Hare, a Master of Public Administration from Nelson Mandela University, and a Bachelor of Arts in Communication from the University of Fort Hare. Some of the further certification and short courses he has completed includes a Certificate in International Higher Education Management from Vanderbilt University, Tennessee State in the USA, and a Compliance Management Certificate from the University of Cape Town. He is a Certified Ethics Officer.
 
Mr Ntsababa was Registrar at the Cape Peninsula University of Technology (CPUT) from April 2012 to April 2019; before that he was Deputy Registrar at CPUT from April 2009 to March 2012. He also served as Director of Governance at the University of Fort Hare from September 2007 to March 2009, and as Faculty Manager: Management and Commerce at the University of Fort Hare from January 2004 to August 2007.   
 
“I look forward to working at the UFS and to share my knowledge and experience of higher-education legislation and the associated regulatory processes, requirements, and trends in the higher-education sector,” says Mr Ntsababa.

Released by:

Lacea Loader (Director: Communication and Marketing)

Telephone: +27 51 401 2584 | +27 83 645 2454

Email: news@ufs.ac.za | loaderl@ufs.ac.za

Fax: +27 51 444 6393



News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept